Trastuzumab emtansine (T-DM1) vs trastuzumab (H) in Chinese patients (pts) with residual invasive disease after neoadjuvant chemotherapy for HER2-positive breast cancer (BC) in the phase III KATHERINE study Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Huang, C
  • Yang, Y
  • Kwong, A
  • Chen, S-C
  • Tseng, L-M
  • Liu, M-C
  • Shen, K
  • Wang, Shusen
  • Ng, T-Y
  • Feng, Y
  • Sun, G
  • Yan, IR
  • Shao, Z

publication date

  • November 2019